SOUTH SAN FRANCISCO, Calif., & PARIS--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) and DNA on demand, has been named to Fast Company’s prestigious annual list of the ...

PARIS--(BUSINESS WIRE)--DNA Script announced today it has been awarded $2.7M in non-dilutive financing from the “Concours d’Innovation” program of Bpifrance. DNA Script was awarded this financing, to ...

Company will receive up to $5 Million in grant funds from DARPA as part of the agency's Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic SOUTH SAN FRANCISCO, ...

DNA Script will receive up to $9.35 million to leverage the company's novel enzymatic DNA synthesis (EDS) technology for the project This is the second announced project[1] where DNA Script has been ...

Following the launch of its benchtop DNA printer earlier this year, DNA Script has secured a hefty $165 million to take its platform to the masses. The nine-digit proceeds represent a big leap in DNA ...

DNA Script, a start-up based in Paris, has won $2.7 million in grants from Bpifrance, a state-backed program for French entrepreneurs. The company uses enzymes, rather than chemical processes, to ...

DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced that it has successfully synthesized the world's first 150-nucleotide (nt) strand of DNA by de novo ...

DNA Script, a leader in enzymatic DNA synthesis, today announced the appointment of Marc Montserrat as its new Chief Executive Officer. In addition, founding CEO Thomas Ybert, PhD, has transitioned to ...

DNA Script was created to revolutionize DNA write with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The ...

DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that ...

Synthesising DNA for Bio Science research and development is costly in terms of time and resources. It’s also a fast-growing, big business. The global Gene Synthesis market will reach over $21 billion ...